Terrence W Norchi is PRESIDENT AND CHIEF EXECUTIVE of Arch Therapeutics, Inc.. Currently has a direct ownership of 6,862 shares of ARTH, which is worth approximately $2,127. The most recent transaction as insider was on Aug 31, 2023, when has been sold 6,862 shares (Common Stock) at a price of $0.28 per share, resulting in proceeds of $1,921. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.86K
0% 3M change
0% 12M change
Total Value Held $2,127

Terrence W Norchi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 31 2023
BUY
Open market or private purchase
$1,921 $0.28 p/Share
6,862 Added 50.0%
6,862 Common Stock
Jul 06 2022
BUY
Grant, award, or other acquisition
-
72,435 Added 2.37%
2,981,512 Common Stock
TWN

Terrence W Norchi

PRESIDENT AND CHIEF EXECUTIVE
Framingham, MA

Track Institutional and Insider Activities on ARTH

Follow Arch Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARTH shares.

Notify only if

Insider Trading

Get notified when an Arch Therapeutics, Inc. insider buys or sells ARTH shares.

Notify only if

News

Receive news related to Arch Therapeutics, Inc.

Track Activities on ARTH